Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
Reprints
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
Ad Orbit Login
Awards
Awards for Excellence Nomination
2025 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Daily E-News Sign Up
Subscribe
Blog
Twitter
Facebook
Google
Linkedin
Magazine
Subscribe
Submit Press Release
Issue Archives
Virtual Issue Archives
Special Sections
Reprints
NJBT E-News
About / Sign Up
Submit Press Release
Archives
NJB News Now
Sponsored Content
Industries
Accounting
Banking / Financial
Coronavirus
Economic Development
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Law
Meeting Places
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Advertising
Upcoming Opportunities
Media Kit Request
File Upload
Ad Orbit Login
Awards
Awards for Excellence Nomination
2025 New Good Neighbor Nomination Form
About
NJB Magazine
NJBIA
Contact
Tag
Drug
Murphy Signs 3 Bills to Lower Drug Costs
Murphy Highlights Prescription Drug Affordability Package
Thomas Edison Partnership to Provide Scholarships for those in Recovery
Certara Acquires Platform for Neurodegenerative Diseases
Horizon Partnership Aims to Lower Cost of Select Generic Drugs
FDA Approves Hoboken-based Octapharma’s Hemophilia Drug
Certara Names New Chief Executive Officer
Merck to Acquire Immune Design
Certara Launches QSP Consortium on Immuno-oncology
Catalent to Acquire Cook Pharmica for $950M
Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Immune Thrombocytopenia
FDA Approves Deltoid Injection Site for Abilify Maintena
FDA Approves Merck’s BELSOMRA® (suvorexant) for the Treatment of Insomnia
Articles by Industry
Accounting
Banking / Financial
Coronavirus
Diversity
Economic Development
Economy
Energy
Environment
General Business
Government
Healthcare
High-Tech
Higher Ed
Infrastructure
Labor
Law
Life Sciences
Manufacturing
Meeting Places
New Hire/Promotion
Philanthropy
Real Estate
Science & Technology
Small Business
Tourism
Workforce Development
Special Sections
Sponsored Content
NEW JERSEY BUSINESS TODAY!
Join our Daily E-News Service
Email
(Required)
First Name
(Required)
Last Name
(Required)
Company
(Required)
Comments
This field is for validation purposes and should be left unchanged.
Δ